BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24068157)

  • 1. Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008.
    Köster M; Grohmann R; Engel RR; Nitsche MA; Rüther E; Degner D
    Psychopharmacology (Berl); 2013 Nov; 230(2):191-201. PubMed ID: 24068157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project.
    Druschky K; Bleich S; Grohmann R; Engel RR; Neyazi A; Stübner S; Toto S
    World J Biol Psychiatry; 2019 Nov; 20(9):732-741. PubMed ID: 30058414
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.
    Spindelegger CJ; Papageorgiou K; Grohmann R; Engel R; Greil W; Konstantinidis A; Agelink MW; Bleich S; Ruether E; Toto S; Kasper S
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP.
    Degner D; Grohmann R; Kropp S; Rüther E; Bender S; Engel RR; Schmidt LG
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S39-45. PubMed ID: 15052513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017.
    Seifert J; Maier HB; Führmann F; Bleich S; Stübner S; Sieberer M; Bernegger X; Greil W; Schüle C; Toto S; Grohmann R; Reinhard MA
    J Neural Transm (Vienna); 2022 Jul; 129(7):925-944. PubMed ID: 35524828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries.
    Druschky K; Bleich S; Grohmann R; Burda K; Frieling H; Hillemacher T; Neyazi A; Stübner S; Toto S
    Eur Psychiatry; 2018 Oct; 54():117-123. PubMed ID: 30193142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI.
    Grohmann R; Rüther E; Engel RR; Hippius H
    Pharmacopsychiatry; 1999 Jan; 32(1):21-8. PubMed ID: 10071179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001-2017.
    Seifert J; Engel RR; Bernegger X; Führmann F; Bleich S; Stübner S; Sieberer M; Greil W; Toto S; Grohmann R
    J Affect Disord; 2021 Feb; 281():547-556. PubMed ID: 33401143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program.
    Konstantinidis A; Papageorgiou K; Grohmann R; Horvath A; Engel R; Kasper S
    Int J Neuropsychopharmacol; 2012 May; 15(4):449-57. PubMed ID: 21733242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project.
    Stübner S; Grohmann R; von Stralendorff I; Rüther E; Möller HJ; Müller-Oerlinghausen B; Engel RR; Horvath A; Greil W
    J Clin Psychiatry; 2010 Oct; 71(10):1293-307. PubMed ID: 20816032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - A drug surveillance report from German-speaking countries.
    Winkler D; Grohmann R; Friedrich ME; Toto S; Bleich S; Seifert J; Konstantinidis A; Shariat SF; Kasper S; Pjrek E
    J Psychiatr Res; 2021 Dec; 144():412-420. PubMed ID: 34741839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program.
    Friedrich ME; Akimova E; Huf W; Konstantinidis A; Papageorgiou K; Winkler D; Toto S; Greil W; Grohmann R; Kasper S
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26721950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017.
    Seifert J; Führmann F; Reinhard MA; Engel RR; Bernegger X; Bleich S; Stübner S; Rüther E; Toto S; Grohmann R; Sieberer M; Greil W
    J Neural Transm (Vienna); 2021 Jun; 128(6):827-843. PubMed ID: 33977402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.
    Stübner S; Grohmann R; Greil W; Zhang X; Müller-Oerlinghausen B; Bleich S; Rüther E; Möller HJ; Engel R; Falkai P; Toto S; Kasper S; Neyazi A
    Int J Neuropsychopharmacol; 2018 Sep; 21(9):814-821. PubMed ID: 29939264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015.
    Glocker C; Grohmann R; Engel R; Seifert J; Bleich S; Stübner S; Toto S; Schüle C
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1425-1435. PubMed ID: 33768297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
    Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
    J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme.
    Letmaier M; Painold A; Holl AK; Vergin H; Engel R; Konstantinidis A; Kasper S; Grohmann R
    Int J Neuropsychopharmacol; 2012 Jul; 15(6):739-48. PubMed ID: 21777511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study.
    Druschky K; Toto S; Bleich S; Baumgärtner J; Engel RR; Grohmann R; Maier HB; Neyazi A; Rudolph YJ; Rüther E; Schwörer H; Seifert J; Stübner S; Degner D
    World J Biol Psychiatry; 2021 Jun; 22(5):373-386. PubMed ID: 32892689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink.
    Bloechliger M; Ceschi A; Rüegg S; Kupferschmidt H; Kraehenbuehl S; Jick SS; Meier CR; Bodmer M
    Drug Saf; 2016 Apr; 39(4):307-21. PubMed ID: 26650063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the prescribing pattern of antidepressant drugs in elderly patients: an Italian, nationwide, population-based study.
    Sultana J; Italiano D; Spina E; Cricelli C; Lapi F; Pecchioli S; Gambassi G; Trifirò G
    Eur J Clin Pharmacol; 2014 Apr; 70(4):469-78. PubMed ID: 24425146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.